Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system
Yingying Hu(Fudan University), Xin Hai(Ningxia Medical University), Xina Li(Harbin Medical University), Jian Gong(Shenyang Pharmaceutical University), Lifu Zhang(Chinese Academy of Sciences), Xiaolin Li(Unknown), Bin Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 98
Related Papers
Anti-cancer natural products isolated from chinese medicinal herbs
|Chinese Medicine|2011|398
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation <i>In Vitro</i> and <i>In Vivo</i>
|Molecular Cancer Therapeutics|2012|223
Fighting fire with fire: Poisonous Chinese herbal medicine for cancer therapy
|Journal of Ethnopharmacology|2012|164
Impacts of COVID-19 on tourists' destination preferences: Evidence from China
|Annals of Tourism Research|2021|160
Human footprint in Tibet: Assessing the spatial layout and effectiveness of nature reserves
|The Science of The Total Environment|2017|159